The Latest

city life

This Week in HIV Research: Welcome to the Real World

May 27, 2021: Recycling tenofovir in a second-line regimen; real-life two-drug regimen failure rates; jump-starting ART at sexual health clinics; viability of wearable devices in sleep assessment.

By Barbara Jungwirth and Myles Helfand
doctor desk

Long-Acting ART Rollout: 3 Considerations for Clinicians

Four months after the approval of cabotegravir/rilpivirine, medical providers still face some tough questions about who might best benefit and how the medication might be covered.

By Larry Buhl
birthday candles

This Week in HIV Research: Getting Wiser About Getting Older

May 6, 2021: Epigenetic aging and HIV treatment initiation; effects of ART on cognitive decline; dearth of osteoporosis screenings for PLWH; physical therapy vs. opioids for bone/muscle pain.

By Barbara Jungwirth and Myles Helfand
nurse patient hands

What's New in U.S. HIV Clinical Treatment Guidelines

The latest update to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV occurred within the pediatric HIV prevention guidelines on April 8.

By Myles Helfand
failure success

This Week in HIV Research: Redefining Failure

April 29, 2021: Measuring HIV drug susceptibility amidst extensive resistance; the reversibility of virologic failure; mobile HIV care in urban settings; whether to prescribe long-acting antiretroviral therapy.

By Barbara Jungwirth and Myles Helfand
Sundararajan Team and TBA

Traditional Healers Offer a Culturally Competent Approach to HIV Testing Gaps

In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.

By Terri Wilder, M.S.W.
David Alain Wohl recaps CROI 2021 research during a video interview

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
clinical trial

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.

HIV Data Bites: Recent Advances in Broadly Neutralizing Antibodies for HIV Prevention

While findings from the high-profile AMP studies have excited scientists, they’re only one of a wide range of bNAb avenues currently being pursued.

By Michael Broder

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl